Introduction
Material quality is an experimental variable. A peptide that differs from its stated identity, carries counter-ion or residual solvent burden, or contains truncated synthesis products can shift results without any obvious signal in the assay. Because research-use-only peptide suppliers are not subject to the pharmacopoeial manufacturing requirements that apply to medicinal products, verification responsibility sits with the receiving laboratory [1,2].
This guide summarizes the documentation and practices commonly examined when a laboratory qualifies a supplier. It is a procurement and documentation guide only; it contains no handling or use protocols.
What makes a supplier research-grade
- Per-lot certificates of analysis. A COA tied to the specific lot shipped, not a generic specimen document, is the baseline expectation.
- Independent testing. Analysis performed by a laboratory other than the manufacturer provides an external check on identity and purity claims.
- Stated analytical methods. Purity determined by reversed-phase HPLC and identity confirmed by mass spectrometry are the standard methods described for synthetic peptides [3,4].
- Catalog transparency. Sequence, molecular formula, molecular weight, and net peptide content should be published rather than supplied only on request.
- Compliant framing. Research-use-only labelling with no therapeutic or use claims anywhere in the listing or supporting content.
How to read a certificate of analysis
A usable COA is traceable to the material in hand. Look first at whether the lot number on the document matches the vial label and whether the analysis date precedes the ship date. Then examine the substance of the report:
- Identity. The observed mass from ESI-MS or MALDI-TOF should match the calculated monoisotopic or average mass for the stated sequence [4].
- Purity. HPLC purity is reported as the percentage of total peak area; the chromatogram itself, with gradient conditions and detection wavelength, should accompany the number [3].
- Net peptide content. Lyophilized peptides contain water and counter-ions, so gravimetric mass overstates peptide mass unless content is separately reported, often by amino acid analysis or nitrogen determination [2].
- Counter-ion and residual solvent. Trifluoroacetate carried over from purification is documented by careful suppliers and is a known confounder in cell-based work [5].
- Appearance, water content, and storage. Recorded on quality-focused documents and useful for stability tracking.
Verification checklist
| What to check | What to look for | Red flag |
|---|---|---|
| COA availability | Lot-specific document published or supplied with the shipment | Single undated example COA reused across the catalog |
| Testing source | Named third-party laboratory, analysis date, and analyst reference | "Tested" claimed with no laboratory named and no report attached |
| Purity method | RP-HPLC percentage with chromatogram and gradient conditions | Purity figure with no method, no trace, and no wavelength |
| Identity method | Mass spectrometry result matched to the calculated mass | No identity confirmation of any kind |
| Product data | Sequence, formula, molecular weight, and net peptide content published | Product name only, with no chemical information |
| Compliance language | Clear research-use-only statement, no use guidance | Dosing charts, administration instructions, or health claims |
| Support and traceability | Reachable technical contact, documented storage and shipping conditions | No contact route, no cold-chain or storage information |
Red flags in supplier marketing
Certain patterns indicate a supplier operating outside research-use norms. Dosing tables, administration instructions, cycle schedules, or before-and-after imagery convert a research listing into a use recommendation and place the vendor outside RUO framing entirely [6]. Therapeutic claims — statements that a compound treats, prevents, or improves a condition — raise the same issue. Other frequently cited signals include purity claims without supporting analytics, catalogs where every item reports an identical purity figure, and testimonial content describing personal use.
Why RUO framing matters for legitimate research
Research-use-only labelling communicates that a material is intended for laboratory investigation and has not been evaluated for diagnostic or therapeutic purposes [6]. For an institution, the distinction affects procurement approval, documentation retention, and record-keeping expectations. A supplier that maintains rigorous RUO framing is also more likely to maintain the analytical documentation that institutional review of purchased materials depends on.
Where to start
Our Trusted Research Suppliers page lists suppliers evaluated against the criteria above: Short Chain Aminos, BioPep, Catalyst Research, Apex Research Services, and Reconstitution Solution. Individual assessments are published under Supplier Reviews. Documentation practices change over time, so verify current COAs and testing records on each supplier's own website before purchase.
Works Cited
- United States Pharmacopeia. General Chapter <1503> Quality Attributes of Synthetic Peptide Drug Substances. Rockville, MD: USP. Available at usp.org.
- European Directorate for the Quality of Medicines & HealthCare. European Pharmacopoeia General Monograph: Substances for Pharmaceutical Use. Strasbourg: EDQM. Available at edqm.eu.
- Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods in Molecular Biology. 2007;386:3–55. doi:10.1007/978-1-59745-430-8_1. PMID: 18604941.
- Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422(6928):198–207. doi:10.1038/nature01511. PMID: 12634793.
- Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. American Journal of Physiology. 1999;277(5):E779–E783. doi:10.1152/ajpendo.1999.277.5.E779. PMID: 10567002.
- U.S. Food and Drug Administration. Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Guidance for Industry and FDA Staff. Silver Spring, MD: FDA. Available at fda.gov.
- International Council for Harmonisation. ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. Geneva: ICH. Available at ich.org.